Copyright
©The Author(s) 2023.
World J Stem Cells. Apr 26, 2023; 15(4): 268-280
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.268
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.268
Figure 1 Experimental design.
The adenine-containing diet was fed from day 0 to day 21, and switched to a standard laboratory diet from day 22 to day 28. Vehicle (IMDM) or UCB-CD34+ cells in IMDM were administered on days 7, 14, and 21 via the tail vein in the control group and cell therapy group, respectively. IMDM: Iscove’s modified Dulbecco’s medium; UCB: Umbilical cord blood.
- Citation: Ohtake T, Itaba S, Salybekov AA, Sheng Y, Sato T, Yanai M, Imagawa M, Fujii S, Kumagai H, Harata M, Asahara T, Kobayashi S. Repetitive administration of cultured human CD34+ cells improve adenine-induced kidney injury in mice. World J Stem Cells 2023; 15(4): 268-280
- URL: https://www.wjgnet.com/1948-0210/full/v15/i4/268.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i4.268